Modelling the epidemiology of hepatitis B in New Zealand.

Hepatitis B is a vaccine preventable disease caused by the hepatitis B virus (HBV) that can induce potentially fatal liver damage. It has the second highest mortality rate of all vaccine preventable diseases in New Zealand. Vaccination against HBV was introduced in New Zealand in 1988, and the country is now categorised with overall low endemicity but with areas of both high and medium endemic levels. We present an SECIR compartmental mathematical model, with the population divided into age classes, for the transmission of HBV using local data on incidence of infection and vaccination coverage. We estimate the basic reproduction number, R(0), to be 1.53, and show that the vaccination campaign has substantially reduced this below one. However, a large number of carriers remain in the population acting as a source of infection.

[1]  Z Xu,et al.  A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in china. , 2000, International journal of epidemiology.

[2]  C. Bullen,et al.  Hepatitis B in a high prevalence New Zealand population: a mathematical model applied to infection control policy. , 2008, Journal of theoretical biology.

[3]  Graham F. Medley,et al.  Hepatitis-B virus endemicity: heterogeneity, catastrophic dynamics and control , 2001, Nature Medicine.

[4]  C. Bullen,et al.  The New Zealand Hepatitis B Screening Programme: screening coverage and prevalence of chronic hepatitis B infection. , 2005, The New Zealand medical journal.

[5]  G A de Wit,et al.  Vaccination against hepatitis B in low endemic countries , 2002, Epidemiology and Infection.

[6]  P. Tiollais,et al.  Hepatitis B virus. , 1991, Scientific American.

[7]  G. Mejía,et al.  Assessment of mycobacteremia detection as a complementary method for the diagnosis of tuberculosis in HIV-infected patients , 2010, European Journal of Clinical Microbiology & Infectious Diseases.

[8]  A J Hall,et al.  The influence of age on the development of the hepatitis B carrier state , 1993, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[9]  J. Juszczyk,et al.  Clinical course and consequences of hepatitis B infection. , 2000, Vaccine.

[10]  D J Nokes,et al.  The transmission dynamics of hepatitis B in the UK: a mathematical model for evaluating costs and effectiveness of immunization programmes , 1996, Epidemiology and Infection.

[11]  M. Roberts,et al.  Predicting and preventing measles epidemics in New Zealand: application of a mathematical model , 2000, Epidemiology and Infection.

[12]  D. Ganem,et al.  Hepatitis B virus infection--natural history and clinical consequences. , 2004, The New England journal of medicine.

[13]  O. Diekmann,et al.  Mathematical Epidemiology of Infectious Diseases: Model Building, Analysis and Interpretation , 2000 .

[14]  O Diekmann,et al.  The construction of next-generation matrices for compartmental epidemic models , 2010, Journal of The Royal Society Interface.

[15]  K. Kaita,et al.  A mathematical model to study the effect of hepatitis B virus vaccine and antivirus treatment among the Canadian Inuit population , 2009, European Journal of Clinical Microbiology & Infectious Diseases.

[16]  G. Macpherson.  Black's Medical Dictionary , 1992 .

[17]  Timothy K. Blackmore,et al.  Immunisation handbook 2006 , 2006 .

[18]  Lan Zou,et al.  Modeling the transmission dynamics and control of hepatitis B virus in China. , 2010, Journal of theoretical biology.

[19]  R. May,et al.  Infectious Diseases of Humans: Dynamics and Control , 1991, Annals of Internal Medicine.

[20]  A. McLean,et al.  Modelling the impact of mass vaccination against hepatitis B. I. Model formulation and parameter estimation , 1994, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[21]  H. Margolis,et al.  Antibody Levels and Protection after Hepatitis B Vaccination: Results of a 15-Year Follow-up , 2005, Annals of Internal Medicine.

[22]  W. Carman,et al.  Current status of HBV vaccine escape variants – a mathematical model of their epidemiology , 1998, Journal of viral hepatitis.

[23]  Jianhua Pang,et al.  Dynamical behavior of a hepatitis B virus transmission model with vaccination. , 2010, Journal of theoretical biology.

[24]  W. Edmunds,et al.  Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areasr , 1996, Epidemiology and Infection.